H
Heron Therapeutics, Inc. (HRTX)
NCM – Real Time Price. Currency in USD
0.43
+0.02 (4.88%)
At close: Jun 26, 2026, 4:00 PM EDT
0.44
+0.01 (1.74%)
After-hours: Jun 26, 2026, 7:47 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.43
+0.02 (4.88%)
At close: Jun 26, 2026, 4:00 PM EDT
0.44
+0.01 (1.74%)
After-hours: Jun 26, 2026, 7:47 PM EDT
No Data
There are no news for this stock.
Total debt $141.6M significantly exceeds cash reserves ($26.1M), raising financial stability concerns
Total current assets $229.0M exceed Total current liabilities $90.5M, highlighting excellent liquidity
Debt-to-equity ratio (15.5) far exceeds the industry average, reflecting over-leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.53 | 6.05 | 10 | |
| Quick ratio | 1.51 | 5.63 | 8.0 | |
| Debt to Equity | 15.50 | 0.30 | 2.0 | |
| Debt to Assets | 0.58 | 1.04 | 4.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 108M | 127M | 144M | 155M | 151M |
| Gross Profit | 53M | 62M | 106M | 114M | 107M |
| Operating Income | -169M | -111M | -12M | -3M | -10M |
| Net Income | -182M | -111M | -14M | -20M | -31M |
| EBITDA | -166M | -108M | -9M | -224K | -8M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 13.24 | 66.67 | 9.0 |
| Next quarter | 12.88 | 93.33 | 9.0 |
| Current year | 8.52 | 55.56 | 8.0 |
| Next year | 4.63 | 81.25 | 7.0 |
| Weighted average score | 8.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -14.47 | -174.57 | -99.99 | 78.97 | 3.3 |
| Y/Y | -10.77 | -407.81 | -499.99 | 78.49 | 3.3 |
| 3y average | 12.97 | 26.09 | 35.84 | 34.71 | 9.5 |
| 5y average | 12.21 | 19.74 | 28.68 | 24.87 | 9.0 |
| Weighted average score | 6.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |